Two new studies examining whether the time of day of CAR-T infusion influences outcomes in relapsed/refractory large B-cell lymphoma arrive at divergent conclusions. Read more in The Hematologist: https://ow.ly/QpaS50Z5yJs
#HemeOnc #Hematology #HemeSky #MedSky
